ABSTRACT
Transcatheter aortic valve implantation may be complicated by the development of conduction disturbances, including left bundle branch block and high-grade atrioventricular blocks, especially in patients with predisposing risk factors, such as pre-existing right bundle branch block. Permanent pacemaker implantation is a procedure with potential short- and long-term complications, and it should be reserved to patients with appropriate indications. Electrophysiological testing and/or prolonged ambulatory ECG monitoring are valuable tools for stratifying the risk of pacemaker implantation. However, the management of new-onset conduction disorders is not always straightforward, and there are different approaches depending on the center's attitude. Therefore, the purpose of this review is to define clinical management based on current evidence, while awaiting data from randomized trials.
Subject(s)
Transcatheter Aortic Valve Replacement , Humans , Transcatheter Aortic Valve Replacement/adverse effects , Incidence , Risk Factors , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Pacemaker, Artificial/adverse effects , Bundle-Branch Block/etiology , Bundle-Branch Block/therapy , Bundle-Branch Block/epidemiology , Aortic Valve Stenosis/surgery , Atrioventricular Block/therapy , Atrioventricular Block/etiology , Atrioventricular Block/epidemiologyABSTRACT
Background: Balloon aortic valvuloplasty (BAV) is a palliative tool for patients with symptomatic severe aortic stenosis (AS) at prohibitive risk for surgery or as a bridge to surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). BAV is traditionally performed in hospitals with onsite cardiac surgery due to its potential complications. Aims: The aim of this study was to evaluate the safety of BAV procedures performed by trained high-volume operators in a centre without onsite surgery and to assess the effect of a minimalistic approach to reduce periprocedural complications. Methods: From 2016 to 2021, 187 BAV procedures were performed in 174 patients. Patients were elderly (mean age: 85.0±5.4 years) and had high-risk (mean European System for Cardiac Operative Risk Evaluation score [EuroSCORE] II: 10.1±9.9) features. According to the indications, 4 cohorts were identified: 1) bridge to TAVR (n=98; 56%); 2) bridge to SAVR (n=8; 5%); 3) cardiogenic shock (n=11; 6%); and 4) palliation (n=57; 33%). BAV procedures were performed using the standard retrograde technique via femoral access in 165 patients (95%), although radial access was used in 9 patients (5%). Ultrasound-guided vascular puncture was performed in 118 patients (72%) and left ventricular pacing was administered through a stiff guidewire in 105 cases (60%). Results: BAV safety was confirmed by 1 periprocedural death (0.6%), 1 intraprocedural stroke (0.6%), 2 major vascular complications (1%) and 9 minor vascular complications (5%). Nine cases of in-hospital mortality occurred (5%), predominantly in patients with cardiogenic shock. Conclusions: BAV is a safe procedure that can be performed in centres without onsite cardiac surgery using a minimalistic approach that can reduce periprocedural complications.
ABSTRACT
Acute aortic dissection is a life-threatening condition that is challenging and difficult to recognize since symptoms may mimic other time-dependent conditions like acute coronary syndrome, acute pulmonary embolism or abdominal conditions. We here describe the case of a middle-aged male with thoraco-abdominal pain, positive ECG and troponin tests that demonstrated a large type A aortic dissection at echocardiography done as part of the acute coronary syndrome work-up. This case report reminds clinicians that acute aortic dissection, although rare, should be considered as a differential diagnosis in the work-up of acute coronary syndrome to avoid critical pitfalls, and echocardiography is crucial to rule out it.
Subject(s)
Acute Coronary Syndrome , Aortic Dissection , Pulmonary Embolism , Acute Coronary Syndrome/diagnostic imaging , Acute Disease , Aortic Dissection/diagnostic imaging , Echocardiography , Humans , Male , Middle AgedABSTRACT
BACKGROUND/AIM: More than half of deaths among hemodialysis patients are due to cardiovascular disease. This study examined whether intravenous administration of ferric carboxymaltose (FCM) has an impact on cardiovascular events in iron-deficient hemodialysis patients. PATIENTS AND METHODS: We performed a retrospective study concerning patients undergoing hemodialysis in our center from September 2016 to December 2019. We identified those who began FCM therapy (FCM group) during this period and those who did not (control group). We analyzed clinical, echocardiographic and laboratory parameters at the beginning (t0) and after one year (t1), to detect differences between the two groups. RESULTS: We identified 53 patients for the FCM group and 19 for the control group. Median follow-up was 1 year±3 months for both groups. In the FCM group, we observed a reduction in the doses of erythropoiesis-stimulating agents (ESA) (p<0.001) and a significative difference in cardiovascular events (p<0.01), but no differences in echocardiographic parameters. CONCLUSION: Patients who received FCM reached satisfactory values of transferrin saturation and ferritin, presented fewer coronary artery events and cardiovascular events, and could reduce doses of ESA.
Subject(s)
Anemia, Iron-Deficiency , Hematinics , Administration, Intravenous , Anemia, Iron-Deficiency/drug therapy , Humans , Iron/therapeutic use , Renal Dialysis , Retrospective StudiesSubject(s)
Cerebral Hemorrhage/mortality , Age Factors , Aged, 80 and over , Comorbidity , Female , Humans , Male , Prospective StudiesABSTRACT
OBJECTIVE: The aim of this study was to determine whether resting ST-T wave abnormalities (ST-Ta) provide incremental prognostic information in patients with no history of coronary artery disease undergoing dobutamine stress echocardiography (DSE). METHODS: We evaluated 1308 consecutive patients without previous myocardial infarction (MI) or revascularization who underwent DSE. Ischemia was defined as new or worsening wall motion abnormalities. End points during follow-up were all-cause death and cardiac death/nonfatal MI. RESULTS: ST-Ta were detected in 162 (12%) patients. The incidence of ischemia was higher in patients with baseline ST-Ta than patients without [74 (46%) vs. 327 (28%), P=0.00001]. During a follow-up of 4.6 ± 3 years, cardiac death/nonfatal MI occurred in 42 (26%) patients with resting ST-Ta and in 157 (14%) patients without resting ST-Ta (P<0.001). Patients with ST-Ta had a higher annual cardiac death/nonfatal MI rate compared with patients without, both in the presence of normal DSE (3.2 vs. 1.4%, P=0.01) as well as abnormal DSE (5.3 vs. 3%, P<0.001). In a Cox proportional modeling, resting ST-Ta added incremental value over clinical and stress echocardiographic data for the prediction of death (global χ 125, 140, 150, respectively; P<0.05) and cardiac death/nonfatal MI (global χ 79, 100, 111, respectively; P<0.05). CONCLUSION: Baseline ST-Ta are associated with an increased risk of cardiac death/nonfatal MI and all-cause mortality, incremental to clinical data and DSE results. The associated risk is persistent among patients with normal DSE.
Subject(s)
Echocardiography, Stress , Electrocardiography , Myocardial Infarction/etiology , Myocardial Ischemia/diagnosis , Aged , Chi-Square Distribution , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Myocardial Infarction/mortality , Myocardial Ischemia/complications , Myocardial Ischemia/mortality , Netherlands , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Retrospective Studies , Risk Assessment , Risk Factors , Time FactorsABSTRACT
PURPOSE: To analyse discharge prescription of recommended treatments in patients with ST-segment elevation myocardial infarction (STEMI) according to reperfusion strategies. METHODS: IN-ACS (Italian Network on Acute Coronary Syndromes) Outcome, an observational, multicenter study, enrolled 6045 ACS patients admitted within 48 h. In the present study we compared the discharge prescription rates of secondary prevention drugs among the 2144 patients with STEMI (72.5% men, age 65+/-13 years) who received primary percutaneous coronary intervention (pPCI) 1044 (48.7%) or thrombolytic therapy (TT) 575 (26.8%) or no reperfusion treatment (NR) 525 (24.5%). RESULTS: Despite the higher risk profile, NR patients respect to pPCI and TT were less frequently receiving antiplatelet (93.0% versus 99.7% versus 96.4%), dual antiplatelet (57.9% versus 93.9% versus 62.8%), beta-blockers (71.2% versus 82.9 versus 75.0%) and statins (68.4% versus 78.6% versus 76.9%) (P <0.0001) at discharge. After multivariable analysis, NR respect to pPCI was an independent predictor of not receiving antiplatelet (OR: 19.6; 95% CI: 6.0-62.5), dual antiplatelet (OR: 10.2; 95% CI: 7.6-13.5), beta-blocker (OR: 1.6; 95% CI: 1.3-2.0). CONCLUSIONS: According to our results NR patients with STEMI, despite their higher risk profile, were less likely to receive the recommended drugs at discharge compared to patients treated with pPCI.
Subject(s)
Angioplasty, Balloon, Coronary/statistics & numerical data , Drug Prescriptions/statistics & numerical data , Myocardial Infarction/therapy , Patient Discharge/statistics & numerical data , Secondary Prevention/organization & administration , Thrombolytic Therapy/statistics & numerical data , Aged , Chi-Square Distribution , Drug Utilization , Female , Guideline Adherence/statistics & numerical data , Humans , Italy/epidemiology , Logistic Models , Male , Middle Aged , Multicenter Studies as Topic , Multivariate Analysis , Myocardial Infarction/diagnosis , Myocardial Infarction/epidemiology , Patient Selection , Practice Guidelines as Topic , Statistics, Nonparametric , Treatment OutcomeABSTRACT
The clinical utility of stress testing in patients without angina pectoris after revascularization has been questioned. Dobutamine stress echocardiography (DSE) is an established technique for detection of myocardial ischemia and cardiac risk stratification. We studied the prognostic value of DSE in 393 patients without typical angina pectoris after coronary revascularization. Ischemia was incremental to clinical data in predicting all-cause death (hazard ratio 3.5, 95% confidence interval 1.8 to 6.7) and cardiac death (hazard ratio 4.2, 95% confidence interval 1.8 to 9.8). In conclusion, myocardial ischemia during DSE is independently associated with an increased risk of all-cause mortality and cardiac death in these patients after adjustment for clinical data.
Subject(s)
Coronary Artery Disease/therapy , Death , Myocardial Ischemia/diagnostic imaging , Myocardial Ischemia/mortality , Myocardial Revascularization , Aged , Angina Pectoris , Echocardiography, Stress , Female , Humans , Male , Middle Aged , Myocardial Ischemia/surgery , Predictive Value of Tests , Prognosis , Risk AssessmentABSTRACT
Economy class stroke syndrome consists of ischemic stroke due to paradoxical embolism through patent foramen ovale after a long flight. Few cases have been described in the literature to date. The treatment choice could be tricky. We present the case of a 65-year-old woman, admitted for submassive pulmonary embolism after a long flight, that presented a paradoxical embolic stroke through patent foramen ovale shortly after. The patient was treated with intravenous thrombolysis within 1 h of stroke onset with a definite symptoms improvement. Afterwards, intravenous unfractioned heparin was started with strict partial thromboplastin time monitoring. Cerebral computed tomography scan, obtained after 24 and 72 h, ruled out hemorrhage. Warfarin was started after 72 h. Patent foramen ovale was percutaneously closed 3 months after. In the reported case, the treatment with thrombolysis and subsequent heparin infusion was effective and safe. We discuss the rationale for this treatment in the light of literature data.
Subject(s)
Aircraft , Anticoagulants/therapeutic use , Cardiac Surgical Procedures , Embolism, Paradoxical/drug therapy , Foramen Ovale, Patent/drug therapy , Pulmonary Embolism/drug therapy , Stroke/drug therapy , Thrombolytic Therapy , Travel , Aged , Echocardiography, Transesophageal , Embolism, Paradoxical/complications , Embolism, Paradoxical/etiology , Embolism, Paradoxical/pathology , Female , Foramen Ovale, Patent/complications , Foramen Ovale, Patent/etiology , Foramen Ovale, Patent/pathology , Foramen Ovale, Patent/surgery , Heparin/therapeutic use , Humans , Pulmonary Embolism/complications , Pulmonary Embolism/pathology , Stroke/etiology , Stroke/pathology , Time Factors , Tomography, X-Ray Computed , Treatment Outcome , Ultrasonography, Doppler, Transcranial , Warfarin/therapeutic useSubject(s)
Aortic Aneurysm/diagnosis , Aortic Rupture/diagnosis , Embryo Transfer/methods , Pregnancy Complications, Cardiovascular/diagnosis , Sinus of Valsalva , Acute Disease , Adult , Diagnosis, Differential , Echocardiography, Doppler , Echocardiography, Transesophageal , Female , Humans , Magnetic Resonance Imaging , PregnancyABSTRACT
Microvascular dysfunction in hypertrophic obstructive cardiomyopathy (HOCM) depends on a complex interplay of functional and anatomic mechanisms. We used myocardial contrast echocardiography in 16 consecutive patients with HOCM (mean age 49 +/- 15 years; 11 men) referred for percutaneous transluminal septal myocardial ablation to assess myocardial perfusion before and 6 months after the procedure. Myocardial contrast echocardiography was performed using real-time imaging during intravenous injection of SonoVue. Myocardial blood velocity (beta) and a semiquantitative assessment of blood volume were obtained in the apical 4-chamber views at midapical septum. Twelve healthy individuals served as control subjects. In patients with HOCM, beta was lower either before (0.17 +/- 0.04 vs 0.50 +/- 0.34 s(-1), P = .006) or after (0.23 +/- 0.07 vs 0.50 +/- 0.34 s(-1), P = .02) successful percutaneous transluminal septal myocardial ablation compared with control subjects. A patchy perfusion pattern was seen in all the patients with HOCM either before or after the procedure. In patients with HOCM percutaneous transluminal septal myocardial ablation improves, but does not normalize microvascular function.
Subject(s)
Cardiomyopathy, Hypertrophic/diagnostic imaging , Cardiomyopathy, Hypertrophic/surgery , Coronary Circulation , Echocardiography/methods , Microcirculation/diagnostic imaging , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/surgery , Cardiomyopathy, Hypertrophic/complications , Catheter Ablation/methods , Ethanol/administration & dosage , Female , Heart Septum/surgery , Humans , Male , Middle Aged , Prognosis , Reproducibility of Results , Sensitivity and Specificity , Treatment Outcome , Ventricular Dysfunction, Left/etiologyABSTRACT
BACKGROUND: Percutaneous transluminal septal myocardial ablation (PTSMA) recently emerged as an alternative to myectomy for hypertrophic obstructive cardiomyopathy (HOCM) patients with drug-refractory symptoms. The target septal branch selection is a main point to achieve the therapeutic result. METHODS AND RESULTS: We report about PTSMA performed using intracardiac echocardiography (ICE) to guide the procedure in 9 symptomatic HOCM patients. The target septal branch was chosen on the basis of the risk-area visualized using ICE after injection of a contrast agent. During alcohol administration a backscattered signal enhancement of the infarcted area was detected. The procedures were uncomplicated and effective to reduce the gradient from 78.9+/-20.4 mmHg to 7.8+/-7.9 mmHg (p<0.0001). CONCLUSIONS: In this initial experience ICE monitoring during PTSMA was safe and provided high quality and continuous imaging of the treated segment of the septum during the whole procedure.
Subject(s)
Angioplasty, Balloon, Coronary/methods , Cardiomyopathy, Hypertrophic/diagnostic imaging , Catheter Ablation/methods , Echocardiography/standards , Adult , Aged , Angioplasty, Balloon, Coronary/adverse effects , Cardiac Pacing, Artificial , Cardiomyopathy, Hypertrophic/therapy , Catheter Ablation/adverse effects , Echocardiography/methods , Female , Heart Block/etiology , Heart Block/therapy , Heart Septum/pathology , Humans , Male , Middle Aged , Myocardium/pathology , Reproducibility of Results , Treatment OutcomeABSTRACT
In all forms of cardiovascular disease, prevalence, incidence, morbidity and mortality are strikingly increased in obese persons, i.e. with elevated Body Mass Index or visceral adiposity. The relative excess risk for coronary events, congestive heart failure and sudden death is 1.5, 2, and 2.8 higher, respectively. Nevertheless, a paradoxical protective effect of obesity has been observed in patients with chronic heart failure, who present a better cardiovascular prognosis, i.e. lower risk of mortality, myocardial infarction, cerebrovascular events and post-PTCA bleedings. Even in patients submitted to cardiac surgery, moderate obesity is not correlated to perioperative morbidity and mortality, although sternal infections, supraventricular arrhythmias, and bleedings are more frequent. In conclusion, obese patients should undergo routine cardiac evaluation to identify those at high risk of cardiovascular events, or those with unknown coronary artery disease or asymptomatic left ventricular dysfunction. Special care should be devoted to the treatment and cardiovascular follow-up of obese patients.
Subject(s)
Cardiovascular Diseases/etiology , Obesity/complications , Body Mass Index , Body Weight , Death, Sudden, Cardiac/etiology , Heart Failure/etiology , Humans , Risk FactorsABSTRACT
BACKGROUND: The purpose of this study was to compare percutaneous transluminal septal myocardial ablation (PTSMA) and septal myectomy combined with mitral leaflet extension (MLE) in symptomatic hypertrophic obstructive cardiomyopathy patients with an enlarged anterior mitral valve leaflet (AMVL). Both PTSMA and myectomy reduce septal thickness and left ventricular outflow tract (LVOT) gradient; however, an uncorrected enlarged AMVL may predispose to residual systolic anterior motion (SAM) after successful standard myectomy or PTSMA. Myectomy with MLE previously demonstrated superior hemodynamic results compared with standard myectomy, but its value relative to PTSMA is unknown. METHODS AND RESULTS: Twenty-nine patients (aged 44+/-12 years) underwent myectomy with MLE, and 43 patients (aged 52+/-17 years) underwent PTSMA. Mitral leaflet area was similar in both groups (16.7+/-3.4 versus 15.9+/-2.7 cm2, respectively). After PTSMA, 2 patients died, 4 needed a reintervention, and 4 required a permanent pacemaker for complete heart block. After surgery, only 1 patient needed a reintervention. At 1-year follow-up, LVOT gradients did not differ between surgical and PTSMA patients (17+/-14 versus 23+/-19 mm Hg, respectively). Preinterventional mitral regurgitation grade was more severe in the surgical group, but with myectomy combined with MLE, the residual grade was similar to that of PTSMA. Mean SAM grade decreased significantly more after surgery (from 2.9+/-0.3 to 0.5+/-0.7 mm Hg versus from 2.8+/-0.5 to 1.3+/-0.9 [corrected], P<0.05). CONCLUSIONS: PTSMA in these selected patients with hypertrophic obstructive cardiomyopathy had more periprocedural complications and resulted in more reinterventions. Hemodynamic results (SAM grade and reduction in mitral regurgitation) were better in surgical patients.
Subject(s)
Cardiomyopathy, Hypertrophic/surgery , Catheter Ablation/methods , Heart Septum/surgery , Mitral Valve/pathology , Adult , Aged , Cardiomyopathy, Hypertrophic/physiopathology , Echocardiography , Follow-Up Studies , Humans , Middle Aged , Postoperative Complications/etiologyABSTRACT
OBJECTIVE: Dobutamine stress echocardiography (DSE), using subjective wall motion scoring, provides incremental prognostic information over clinical data. The aim of the study was to test the additional prognostic value of left ventricular ejection fraction (LVEF) changes during DSE at different stages. METHODS: The study population comprised 106 consecutive patients (mean age 60+/-11 years, 73% men) with suspected or known coronary artery disease referred for DSE. Stress-induced ischemia was defined as new or worsening wall motion abnormalities. LVEF was measured at rest, peak stress and recovery. Follow-up was successful in 104 (98%) patients. Four patients who underwent revascularization within 60 days were excluded from the analysis. End-points during follow-up were cardiac death, non-fatal myocardial infarction and late revascularization. RESULTS: During a mean follow-up of 5.3+/-2.1 years, 26% of patients died: 13% due to cardiac death, 6% patients experienced non-fatal myocardial infarction and 38% underwent late revascularization. Rest-to-peak LVEF increase was lower in patients who experienced cardiac death or non-fatal myocardial infarction (4.9+/-8.6 compared with 9.2+/-7.5, P=0.04) and any cardiac events (6.0+/-8.5 compared with 10.5+/-6.7, P=0.004). An inverse correlation was found between left ventricular ejection increase and the number of ischemic segments (P<0.0001). A multivariable Cox proportional hazard model demonstrated that, in addition to clinical data and new wall motion abnormalities, lower LVEF increase had an incremental prognostic value in predicting hard cardiac events (hazard ratio 1.1, 95% confidence interval 1.0-1.2). CONCLUSION: Failure of LVEF to significantly increase during DSE, denoting more extensive ischemia, identifies a higher-risk subgroup for late cardiac events.
Subject(s)
Anti-Arrhythmia Agents/administration & dosage , Atropine/administration & dosage , Coronary Artery Disease/diagnosis , Coronary Artery Disease/physiopathology , Echocardiography, Stress , Stroke Volume , Aged , Death, Sudden, Cardiac/pathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Multivariate Analysis , Myocardial Infarction/diagnosis , Myocardial Infarction/physiopathology , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Reproducibility of ResultsABSTRACT
PURPOSE: This study assessed the incremental value of dobutamine stress ( 99m)Tc-tetrofosmin single-photon emission computed tomography (SPECT) for the prediction of cardiac events in diabetic patients with limited exercise capacity. METHODS: The study population comprised 125 consecutive diabetic patients (mean age 61+/-9 years, 61% men) who were unable to perform an exercise test and underwent dobutamine ( 99m)Tc-tetrofosmin SPECT. Follow-up was successful in 124 (99%) patients. Three patients who underwent early revascularisation (within 60 days) were excluded. End-points during follow-up were cardiac death and non-fatal myocardial infarction. RESULTS: An abnormal scan (with the presence of reversible or fixed perfusion defects) was observed in 76 (63%) patients. During the follow-up (3.4+/-1.5 years), 36 patients died (19 cardiac deaths) and four patients had non-fatal myocardial infarction. Cardiac death occurred in one of 49 (2%) patients with a normal myocardial perfusion study and in 18 of 75 (24%) patients with an abnormal study (p<0.001). Abnormal scan was incremental to the clinical parameters in predicting cardiac death (chi(2)=48 vs 39, p<0.05) and hard cardiac events (chi(2)=50 vs 43, p<0.05). CONCLUSION: Dobutamine stress ( 99m)Tc-tetrofosmin SPECT provides prognostic information additional to clinical data for the prediction of cardiac death and hard cardiac events in diabetic patients unable to perform an exercise test.
Subject(s)
Atropine , Diabetes Mellitus/diagnostic imaging , Diabetes Mellitus/mortality , Dobutamine , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/mortality , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/mortality , Age Distribution , Comorbidity , Diabetes Mellitus/diagnosis , Exercise Test/statistics & numerical data , Exercise Tolerance , Female , Humans , Male , Middle Aged , Myocardial Infarction/diagnosis , Netherlands/epidemiology , Prognosis , Radionuclide Imaging , Radiopharmaceuticals , Reproducibility of Results , Risk Assessment/methods , Risk Factors , Sensitivity and Specificity , Sex Distribution , Ventricular Dysfunction, Left/diagnosisABSTRACT
UNLABELLED: Information on the prognostic value of noninvasive stress imaging techniques in the elderly is relatively scarce. This study assessed the prognostic value of dobutamine stress (99m)Tc-tetrofosmin SPECT for the prediction of mortality and cardiac events in elderly patients. METHODS: Clinical information and SPECT results were analyzed for 272 consecutive patients > or = 65 y old (mean age, 71 +/- 5 y; range, 65-87 y) with limited exercise capacity. Follow-up was complete in 270 patients (99.3%); 23 underwent revascularization within 60 d of the scintigraphy and were excluded. Abnormal findings were defined as the presence of a fixed or reversible perfusion defect. A summed stress score was obtained to estimate the extent and severity of perfusion defects. The incremental prognostic value of SPECT over clinical data was evaluated according to 3 multivariate models, which included any SPECT abnormality, the presence of a fixed or reversible defect, and the summed stress score. RESULTS: During the follow-up (3.3 +/- 1.4 y), 59 patients died (29 cardiac deaths), 16 had a nonfatal infarction, and 49 underwent late revascularization. Abnormal scan findings were present for 140 patients (57%). The annual event rates for total mortality, cardiac death, and cardiac death or nonfatal infarction were, respectively, 3.2%, 0.2%, and 0.7% when scan findings were normal and, respectively, 9.5%, 4.3%, and 8% when scan findings were abnormal (all P < 0.0001). Multivariate analysis showed that abnormal scan findings, the presence of a fixed or reversible defect, and the summed stress score provided incremental prognostic information over clinical data. The presence of abnormal scan findings was independently associated with an increased risk for total mortality, cardiac death, and cardiac death or nonfatal infarction (respectively, hazard ratio 3.4 [95% CI, 1.8-6.5], 12.1 [95% CI, 2.9-51.5], and 9.0 [95% CI, 2.8-29.6]). CONCLUSION: Dobutamine stress (99m)Tc-tetrofosmin SPECT provides incremental prognostic information for the prediction of total mortality and cardiac events in elderly patients.
Subject(s)
Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/mortality , Dobutamine , Organophosphorus Compounds , Organotechnetium Compounds , Risk Assessment/methods , Tomography, Emission-Computed, Single-Photon/statistics & numerical data , Aged , Aged, 80 and over , Causality , Comorbidity , Coronary Artery Disease/diagnosis , Exercise Test , Female , Geriatric Assessment/methods , Geriatric Assessment/statistics & numerical data , Humans , Male , Myocardial Infarction/diagnosis , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/mortality , Netherlands/epidemiology , Prognosis , Radiopharmaceuticals , Reproducibility of Results , Risk Factors , Sensitivity and Specificity , Survival AnalysisABSTRACT
The presence of a right bundle branch block (RBBB) is associated with increased mortality. We studied the role of dobutamine stress echocardiography for the prognostic stratification of patients with RBBB. The presence of an abnormal dobutamine stress echocardiography was the strongest predictor of cardiac events and provided incremental prognostic information to clinical and stress test data.
Subject(s)
Bundle-Branch Block/diagnosis , Echocardiography, Stress , Aged , Blood Pressure/physiology , Bundle-Branch Block/epidemiology , Bundle-Branch Block/physiopathology , Electrocardiography , Female , Follow-Up Studies , Heart Failure/diagnosis , Heart Failure/epidemiology , Heart Failure/physiopathology , Heart Rate/physiology , Humans , Incidence , Male , Middle Aged , Multivariate Analysis , Myocardial Ischemia/diagnosis , Myocardial Ischemia/epidemiology , Myocardial Ischemia/physiopathology , Predictive Value of Tests , Prognosis , Systole/physiologyABSTRACT
This study analyzed the relations and time-related changes in eligibility for cardiac resynchronization therapy and prophylactic defibrillator implantation in 161 potential candidates for heart transplantation. Although up to 62% of patients who fulfilled the severity criteria for heart transplantation were eligible for either device, this percentage increased as clinical/instrumental parameters of heart failure severity worsened.